Clinical Trial

The Role of CD34+ Stem Cells in the Pathogenesis of Takotsubo Syndrome

Study acronym: STRESS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 22, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The underlying mechanisms of microvascular dysfunction in Takotsubo cardiomyopathy remain incompletely understood. As CD34+ cells are essential to coronary microvascular homeostasis we will investigate the potential association between CD34+ cell count and changes in left ventricular function in patients with Takotsubo cardiomyopathy at baseline and 6-month follow-up.
Trial Details
NCT Number NCT07604467
Lead Sponsor University Medical Centre Ljubljana
Conditions Tako Tsubo Cardiomyopathy, Microvascular Dysfunction, CD34+ Stem Cells, Heart Failure, Cardiac Contractility Recovery
Enrollment 40 participants
Start Date 2021-09-06
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-22